Neuraxis Inc
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About Neuraxis Inc
Neuraxis Inc is a growth stage company is engaged in developing neuromodulation therapies to address chronic and debilitating conditions in children. The company is dedicated to advancing the science with its’ proprietary Percutaneous Electrical Nerve Field Stimulation (PENFS) technology. The company focuses on targeted therapies for the pediatric and adolescent population suffering from disorders of gut-brain interaction (DGBIs).
/ 
Others were interested in
See all stocksFrequently asked questions
To buy Neuraxis Inc stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for Neuraxis Inc by name or ticker, choose the number of shares, and place your order.
The ticker symbol for Neuraxis Inc is NRXS:xase. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
Neuraxis Inc has its primary listing on NYSE American. You can trade Neuraxis Inc with a Saxo account, alongside thousands of other stocks worldwide.
Yes, Neuraxis Inc is available to trade on SaxoInvestor and SaxoTraderGO. You can buy shares directly and include Neuraxis Inc as part of a broader investment portfolio. Explore our SaxoInvestor platform.
Learn more about investing and trading at Saxo’s educational content hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures— so you can make more informed decisions when considering shares like Neuraxis Inc.